Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,952 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07264270RecruitingPhase 1
A new injection for long-term sciatica pain
This trial tests a new medicine called C-1101, given as a shot into the spine, to see if it safely reduces pain from chronic sciatica. It is for people who have not gotten enough relief from standard treatments.
Broadmeadow, New South WalesAges 18–65 - NCT07265284RecruitingPhase 3
IBI112 for teens with moderate to severe plaque psoriasis
This study tests a new medicine called IBI112 for teens aged 12–18 with moderate to severe plaque psoriasis. It aims to see if the medicine is safe and can help clear skin better than placebo.
Beijing, Beijing MunicipalityAges 12–18 - NCT07265297RecruitingPhase 3
Hydroxychloroquine for fatty liver disease with inflammation
This trial tests if hydroxychloroquine, a medicine used for other conditions, can reduce liver inflammation in people with fatty liver disease. It aims to help those whose fatty liver has caused ongoing liver damage.
Taipei, TaiwanAges 18 years+ - NCT07266805RecruitingPhase 3
Oral deucrictibant for preventing and treating angioedema attacks in AAE-C1INH
This trial tests two forms of an oral medication to prevent and treat sudden swelling attacks in people with a rare condition called acquired angioedema due to C1 inhibitor deficiency. It aims to see if the drug can reduce attack frequency and manage acute episodes.
San Diego, CaliforniaAges 18 years+ - NCT07267845Recruiting
Effect of alpha-GPC on thinking and exercise performance
This study tests whether a supplement called alpha-GPC (a nutrient that supports brain health) can improve memory, thinking, and physical performance in healthy adults. You would take the supplement and complete cognitive tests and exercise tasks over several visits.
Cork, County CorkAges 25–55 - NCT07268846Recruiting
Prebiotic supplement before colorectal cancer surgery
This trial tests if taking a postbiotic supplement before surgery for colorectal cancer can improve recovery. It may help patients with adenocarcinoma of the large intestine prepare for their operation.
São Paulo, São PauloAges 18 years+ - NCT07271576Recruiting
Phycocyanin study for liver fibrosis and cirrhosis
This trial tests if phycocyanin (a natural blue pigment from spirulina) can help protect the liver and slow damage from fibrosis or cirrhosis. It may be an option if you have stable liver disease and are looking for supportive therapy.
HangzhouAges 18–75 - NCT07273721RecruitingPhase 2
Testing BT200 in type 2B von Willebrand disease
This trial tests a new medicine called BT200 (rondaptivon pegol) to see if it can safely help people with type 2B von Willebrand disease who have low platelets and recent bleeding problems.
Vienna, State of ViennaAges 18 years+ - NCT07273838RecruitingPhase 2
SGLT2 inhibitor for acute heart and kidney failure
This study tests whether a medicine called an SGLT2 inhibitor (which lowers blood sugar and helps the kidneys) can improve outcomes for people with acute heart failure and kidney problems. Participation involves taking the study drug or a placebo for a short time.
New Haven, ConnecticutAges 18–85 - NCT07275515RecruitingPhase 2
Diroximel fumarate for brain bleed swelling
This study tests a medicine called diroximel fumarate to reduce swelling around a bleeding stroke (intracerebral hemorrhage). If you or your loved one have had a brain bleed within the last 48 hours and are not too severely affected, you may be able to join.
LilleAges 18 years+ - NCT07275749RecruitingPhase 3
Acetyl-leucine for balance problems after a stroke
This trial tests if acetyl-leucine can help improve walking and balance in people who had a specific type of stroke in the back part of the brain. You may qualify if you had your first stroke there and have trouble with balance or walking.
Kafr ash ShaykhAges 18–80 - NCT07275788RecruitingPhase 1
Study of REGEND003 for type 2 diabetes with kidney disease
This trial tests a new treatment, REGEND003, for people who have both type 2 diabetes and chronic kidney disease. The goal is to see if it can help manage these conditions together.
ShanghaiAges 30–75 - NCT07275918RecruitingPhase 1
Study of SA1211 injection for chronic hepatitis B
This study tests a new injection called SA1211 for people with chronic hepatitis B. It will help see if the treatment is safe and how it works in the body.
Changchun, JilinAges 18–65 - NCT07276282RecruitingPhase 3
Ziltivekimab for heart attack patients with artery plaque
This trial tests a new drug called Ziltivekimab to see if it can reduce plaque buildup in the heart arteries after a heart attack. It may help prevent future heart problems by targeting inflammation.
BernAges 18 years+ - NCT07276581RecruitingPhase 2
Testing AZD1163 for active rheumatoid arthritis
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
Glendale, ArizonaAges 18 years+ - NCT07276997RecruitingPhase 2
Study of Icalcaprant for major depressive disorder
This trial tests an oral medication called icalcaprant for adults with major depressive disorder (MDD). It aims to see if the drug can reduce depression symptoms and what side effects may occur.
Dothan, AlabamaAges 18–65 - NCT07278505RecruitingPhase 1/Phase 2
CBD and brain imaging study for young adults with stress
This trial tests whether cannabidiol (CBD), a compound from cannabis, can help reduce stress in young adults who have experienced early-life adversity. You will have brain scans and take CBD or a placebo to see how it affects your stress and anxiety.
New York, New YorkAges 18–25 - NCT07279194RecruitingPhase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes
This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.
ShanghaiAges 18 years+ - NCT07279493RecruitingPhase 2
Testing KPCXM18 injection for acute ischemic stroke within 12 hours
This trial tests an investigational injection called KPCXM18 for people having an acute ischemic stroke. It is given within 12 hours of symptom onset, in addition to standard clot-dissolving treatment, to see if it improves recovery and safety.
Beijing, Beijing MunicipalityAges 18–80 - NCT07279558RecruitingPhase 2
CBD and Alcohol Use Study
This study tests whether cannabidiol (CBD), a compound from cannabis, can help people who drink alcohol regularly reduce their drinking or change their drinking patterns. You may be eligible if you're 21-65, have used CBD or cannabis before, drink alcohol regularly, and don't take certain medications that could interfere.
Aurora, ColoradoAges 21–65 - NCT07280585RecruitingPhase 3
Testing a diabetes drug to slow kidney disease progression
This study tests whether a common diabetes medication (SGLT2 inhibitor) can help people with autosomal dominant polycystic kidney disease (ADPKD) maintain kidney function longer. If you have fast-growing kidney cysts and are between 18 and 60 years old, this trial may be an option.
FeldkirchAges 18–60 - NCT07280936RecruitingPhase 1
Study of SHR-2906 in healthy people and those with obesity
This trial tests a new injection called SHR-2906, first in healthy people to check safety, then in people with obesity to see how well it works. It may help with weight management.
Hangzhou, ZhejiangAges 18–55 - NCT07282145RecruitingPhase 1
BCD101 Safety Study in Healthy Volunteers
This trial tests the safety of a new drug called BCD101 in healthy people. It checks how the drug moves through the body and if it causes any side effects.
Cheongju-si, North ChungcheongAges 19 years+ - NCT07282600RecruitingPhase 3
Study of eloralintide for type 2 diabetes and weight
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
Birmingham, AlabamaAges 18 years+
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,952 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.